Masur, H. et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 305, 1431–1438 (1981).

Article  CAS  PubMed  Google Scholar 

Palella, F. J. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338, 853–860 (1998).

Article  PubMed  Google Scholar 

Weverling, G. J. et al. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. Lancet 353, 1293–1298 (1999).

Article  CAS  PubMed  Google Scholar 

Gingo, M. R. et al. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS ONE 8, e58812 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Segal, L. N. et al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc. Am. Thorac. Soc. 8, 282–287 (2011).

Article  PubMed  PubMed Central  Google Scholar 

SeyedAlinaghi, S. et al. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. Eur. J. Med. Res. 27, 195 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Gingo, M. R., Morris, A. & Crothers, K. Human immunodeficiency virus-associated obstructive lung diseases. Clin. Chest Med. 34, 273–282 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Gingo, M. R. et al. Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J. Allergy Clin. Immunol. 129, 708–714.e8 (2012).

Article  PubMed  Google Scholar 

Drummond, M. B. et al. Association between HIV and prevalence and manifestations of asthma: analysis of the Multicenter AIDS Cohort Study and Women’s Interagency HIV Study. J. Acquir. Immune Defic. Syndr. https://doi.org/10.1097/QAI.0000000000003088 (2022).

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. World Health Statistics 2022: Monitoring Health for the SDGs, Sustainable Development Goals (WHO, 2022).

Crothers, K. et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am. J. Respir. Crit. Care Med. 183, 388–395 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Phair, J. et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N. Engl. J. Med. 322, 161–165 (1990).

Article  CAS  PubMed  Google Scholar 

Stansell, J. D. et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary complications of HIV Infection Study Group. Am. J. Respir. Crit. Care Med. 155, 60–66 (1997).

Article  CAS  PubMed  Google Scholar 

Horsburgh, C. R. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med. 350, 2060–2067 (2004).

Article  CAS  PubMed  Google Scholar 

Andrews, J. R. et al. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin. Infect. Dis. 54, 784–791 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Sloot, R. S., van der Loeff, M. F., Kouw, P. M. & Borgdorff, M. W. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am. J. Respir. Crit. Care Med. 190, 1044–1052 (2014).

Article  PubMed  Google Scholar 

Menzies, N. A. et al. Time since infection and risks of future disease for individuals with Mycobacterium tuberculosis infection in the United States. Epidemiology 32, 70–78 (2021).

Article  PubMed  Google Scholar 

Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Clinical Info HIV.gov https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection (2023).

World Health Organization. Global tuberculosis report 2022. WHO https://www.who.int/publications/i/item/9789240061729 (2022).

Hirschtick, R. E. et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N. Engl. J. Med. 333, 845–851 (1995).

Article  CAS  PubMed  Google Scholar 

Kohli, R. et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV Epidemiologic Research (HER) study. Clin. Infect. Dis. 43, 90–98 (2006).

Article  PubMed  Google Scholar 

Balakrishna, S. et al. Decreasing incidence and determinants of bacterial pneumonia in people with HIV: the Swiss HIV Cohort Study. J. Infect. Dis. https://doi.org/10.1093/infdis/jiab573 (2021).

Article  Google Scholar 

Mussini, C. et al. Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort. J. Acquir. Immune Defic. Syndr. 63, 339–345 (2013).

Article  CAS  PubMed  Google Scholar 

Sullivan, J. H., Moore, R. D., Keruly, J. C. & Chaisson, R. E. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am. J. Respir. Crit. Care Med. 162, 64–67 (2000).

Article  CAS  PubMed  Google Scholar 

Bénard, A. et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS ONE 5, e8896 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Kaplan, J. E., Hanson, D. L., Navin, T. R. & Jones, J. L. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J. Infect. Dis. 178, 1126–1132 (1998).

Article  CAS  PubMed  Google Scholar 

Wood, R., Maartens, G. & Lombard, C. J. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J. Acquir. Immune Defic. Syndr. 23, 75–80 (2000).

Article  CAS  PubMed  Google Scholar 

Girardi, E. et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14, 1985–1991 (2000).

Article  CAS  PubMed  Google Scholar 

Girardi, E. et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin. Infect. Dis. 41, 1772–1782 (2005).

Article  PubMed  Google Scholar 

Severe, P. et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N. Engl. J. Med. 363, 257–265 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badri, M., Wilson, D. & Wood, R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359, 2059–2064 (2002).

Article  PubMed  Google Scholar 

del Amo, J. et al. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin. Infect. Dis. 54, 1364–1372 (2012).

Article  PubMed  Google Scholar 

Gordin, F. M. et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am. J. Respir. Crit. Care Med. 178, 630–636 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Mdodo, R. et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann. Intern. Med. 162, 335–344 (2015).

Article  PubMed  Google Scholar 

Mdege, N. D., Shah, S., Ayo-Yusuf, O. A., Hakim, J. & Siddiqi, K. Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries. Lancet Glob. Health 5, e578–e592 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Pacek, L. R. & Crum, R. M. A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addict. Res. Theory 23, 10–23 (2015).

Article  PubMed  Google Scholar 

Helleberg, M. et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin. Infect. Dis. 56, 727–734 (2013).

Article  PubMed  Google Scholar 

Cornelius, M. E., Wang, T. W., Jamal, A., Loretan, C. G. & Neff, L. J. Tobacco product use among adults – United States, 2019. Morb. Mortal. Wkly Rep. 69, 1736–1742 (2020).

Article  Google Scholar 

Asfar, T. et al. National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999-2016). Nicotine Tob. Res. 23, 1308–1317 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Murphy, J. D., Liu, B. & Parascandola, M. Smoking and HIV in sub-Saharan Africa: a 25-country analysis of the demographic health surveys. Nicotine Tob. Res. 21, 1093–1102 (2019).

Article  PubMed  Google Scholar 

Bigna, J. J., Kenne, A. M., Asangbeh, S. L. & Sibetcheu, A. T. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. Lancet Glob. Health 6, e193–e202 (2018).